EVALUATE THE RELATIONSHIP BETWEEN EOSINOPHILS AND COVID-19 PATIENTS.
Keywords:
Eosinophils, Covid-19, Cells, ComorbiditiesAbstract
This study aims to evaluate and know the relationship between eosinophilia and COVID-19 patients Patients were collected from different hospitals in Iraq, where 50 patients were collected and divided into two groups with eosinophilia that included 30 patients, and without eosinophilia, 20 patients After obtaining the necessary approvals from the Ethics Committee to carry out this study, it will study and analyze the demographic data of patients for a period of one full year from 5-5-2020 to 6-9-2021, and we found A positive relationship was found between eosinophilia in Covid-19 patients
References
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., and Cheng, Z., 2020. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet, 395(10223), pp.497-506.
Carlos, W.G., Dela Cruz, C.S., Cao, B., Pasnick, S. and Jamil, S., 2020. Novel Wuhan (2019-nCoV) Coronavirus. Am J Respir Crit Care Med, pp.P7-P8.
Alexpandi R, Mesquita JFD, Pandian SK, Ravi AV. Quinolines-based SARS-CoV-2 3CLpro and RdRp inhibitors and spike-RBD-ACE2 inhibitor for drug-repurposing against COVID-19: an in-silico analysis. Front Microbiol 2020; 11:1796.
Wu CM, Chen XY, Cai YP, Xia JA, Zhou X, Xu S. Risk factors associated with acute respiratory distress syndrome anddeath in patients with coronavirus disease 2019 pneumonia in Wuhan. China JAMA Intern Med 2020; 180:934–43.
Zhou YL, Zhang ZC, Tian J, et al. Risk factors associated with disease progression in a cohort of patients infected with the 2019 novel coronavirus. Anna Palliat Med 2020; 9:428–36. [PubMed] [Google Scholar]
Rodrigo-Muñoz JM, Sastre B, Cañas JA, Gil-Martínez M, Redondo N, Del Pozo V. Eosinophil response against classical and emerging respiratory viruses: COVID-19. J Investig Allergol Clin Immunol 2021; 31:94–107. [PubMed] [Google Scholar]
Lippi G, Henry BM. Eosinophil count in severe coronavirus disease 2019. Qjm 2020; 113:511–2.
Yang J, Zhao X, Liu X, Sun W, Zhou L, Wang Y. Clinical characteristics and eosinophils in young SARS-CoV-2-Positive Chinese travelers returning to Shanghai. Front Public Health 2020; 8:368.
Sun S, Cai X, Wang H, et al. Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China. Clin Chim Acta 2020; 507:174–80.
Sun Y, Dong Y, Wang L, Xie H, Li B, Chang C. Characteristics and prognostic factors of disease severity in patients with COVID-19: the Beijing experience. J Autoimmun 2020; 112:102473.
Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan. China Allergy 2020; 75:1730–41. [PubMed] [Google Scholar]
Wang ZL, Yang BH, Li QW, Lu W, Zhang RG. Clinical features of 69 cases with coronavirus disease 2019 in Wuhan. China Clin Infect Dis 2020; 71:769–77.
Chen J, Pan Y, Li G, Xu W, Zhang L, Yuan S. Distinguishing between COVID-19 and influenza during the early stages by measurement of peripheral blood parameters. J Med Virol 2021; 93:1029–37.
Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan. China Clin Infect Dis 2020; 71:762–8
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
